Data Integrity Compliance

Data integrity compliance ensures pharmaceutical data quality, authenticity, and reliability throughout manufacturing, testing, and quality systems meeting regulatory expectations for electronic and paper-based information. ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate, plus complete, consistent, enduring, available) establish standards for data acceptability. Electronic systems require validated software, appropriate access controls, user authentication, and complete audit trails documenting all data modifications. Quality management systems incorporate data integrity into risk assessments identifying systems requiring enhanced controls.

Regulatory inspections increasingly focus on data integrity with significant observations resulting from inadequate controls, anomalous record patterns, or incomplete audit trails. Laboratories and manufacturing facilities implement comprehensive data governance programmes addressing electronic records management, backup systems, and disaster recovery protocols. Analyst training emphasises professional obligations for data truthfulness and significance of regulatory consequences for data falsification. Third-party vendors and contract manufacturing organisations require equivalent data integrity standards with audit confirmation. Deficient data integrity findings represent serious regulatory violations potentially resulting in warning letters, consent decrees, or criminal prosecution.